Skip to search.
 TSX Down 0.39% TSX Ventures Down 0.02%

Celgene Corporation (CELG)

-NasdaqGS
114.65 Down 1.37(1.18%) 2:13PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:116.02
Open:115.84
Bid:114.56 x 100
Ask:114.59 x 200
1y Target Est:137.62
Beta:1.79
Earnings Date:Jul 22 - Jul 27 (Est.)
Day's Range:114.35 - 116.23
52wk Range:75.62 - 129.06
Volume:1,445,133
Avg Vol (3m):5,343,570
Market Cap:90.93B
P/E (ttm):39.21
EPS (ttm):2.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.18%90.93B
JNJDown 0.07%280.23B

Key Statistics

Forward P/E (1 yr):18.51
P/S (ttm):11.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.75
Quarterly EPS Est (Jun-15) :1.14
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback